She was inspired to pursue research during her first clinical traineeship in radiology when she realized the routine clinical imaging approaches had not kept pace with the rapid development of novel targeted cancer therapies. 2/6
She is most excited about the development of new molecular imaging techniques that enable early response assessment to targeted therapies, and thus, optimize individualized treatment regimes. 3/6
After finishing medical school, she is considering pursuing an MD-PhD to aspire to a future career as a clinician scientist, working on translational oncologic imaging approaches to bridge the gap between research and clinical practice. 4/6
She is “delighted to have published our work in JITC as their broad readership meets the strong interdisciplinarity of cancer immunotherapies.” 5/6
When not in the lab or clinics, Emily enjoys competing, coaching or judging gymnastics.
Meet the Author: Alexandra Beckett (@itsalexbeckett), a PhD candidate and #ECR from St. Jude Children’s Research Hospital @StJudeResearch@stjudegraduate, is 1st author of “CD47 expression is critical for CAR T cell survival in vivo”, recently published in #JITC! 1/7
She was inspired to become a researcher to combine her drive to constantly learn with her desire to make a positive impact in the world by developing novel cancer therapies. 2/7
She is most excited about cell and gene therapy, and would like to work as an R&D scientist to someday contribute to the development of a new therapy that helps someone. 3/7